Clinical Trial Update: Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 comparative trial evaluating the efficacy and safety of BCD-055 versus Remicade in combination with methotrexate in active rheumatoid arthritis has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BCD-055 (infliximab biosimilar)
• Remicade (infliximab)

Snippet

Sponsor: Biocad | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED